Luan César Silva Selected Research

Mucoepidermoid Carcinoma

1/2023	Repurposing NFκB and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas.
1/2023	Oral squamous cell carcinoma cancer stem cells have different drug sensitive to pharmacological NFκB and histone deacetylation inhibition.
7/2022	Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luan César Silva Research Topics

Disease

4	Neoplasms (Cancer) 01/2023 - 01/2022
3	Mucoepidermoid Carcinoma 01/2023 - 07/2022
2	Squamous Cell Carcinoma of Head and Neck 01/2024 - 01/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2024
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2023

Drug/Important Bio-Agent (IBA)

2	Histone Deacetylase InhibitorsIBA 01/2023 - 01/2023
2	Histones (Histone)IBA 01/2023 - 07/2022
1	Sirolimus (Rapamycin)FDA Link 01/2024
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2024
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2024
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	EmetineIBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	Lysine (L-Lysine)FDA Link 07/2022
1	cephaelinIBA 07/2022
1	Keratins (Keratin)IBA 01/2022

Therapy/Procedure

3	Therapeutics 01/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2023